Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Other Non-Current Assets (2018 - 2023)

Historic Other Non-Current Assets for CollPlant Biotechnologies (CLGN) over the last 6 years, with Q4 2023 value amounting to $26.7 million.

  • CollPlant Biotechnologies' Other Non-Current Assets fell 1068.18% to $26.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $26.7 million, marking a year-over-year decrease of 1068.18%. This contributed to the annual value of $26.7 million for FY2023, which is 1408829.79% up from last year.
  • CollPlant Biotechnologies' Other Non-Current Assets amounted to $26.7 million in Q4 2023, which was down 1068.18% from $29.9 million recorded in Q4 2022.
  • Over the past 5 years, CollPlant Biotechnologies' Other Non-Current Assets peaked at $41.3 million during Q1 2022, and registered a low of $3.5 million during Q4 2020.
  • Moreover, its 5-year median value for Other Non-Current Assets was $17.7 million (2021), whereas its average is $18.4 million.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Other Non-Current Assets plummeted by 2987.82% in 2019, and later soared by 27929.67% in 2021.
  • Quarter analysis of 5 years shows CollPlant Biotechnologies' Other Non-Current Assets stood at $4.0 million in 2019, then dropped by 11.21% to $3.5 million in 2020, then surged by 279.3% to $13.4 million in 2021, then soared by 123.3% to $29.9 million in 2022, then fell by 10.68% to $26.7 million in 2023.
  • Its Other Non-Current Assets stands at $26.7 million for Q4 2023, versus $29.9 million for Q4 2022 and $36.5 million for Q2 2022.